Sheffield Children's takes on EONIS-Q newborn screening for NHS England
- NHS England
- South East
- 3 bids
Sheffield Children's NHS Foundation Trust provides newborn screening lab work for NHS England using the EONIS-Q methodology.
The work belongs to the NHS Newborn Blood Spot in-service evaluation for Severe Combined Immuno-Deficiency (SCID), to which the UK NSC recommended adding Spinal Muscular Atrophy (SMA). The trust must keep methods and validation consistent across lab sites, provide capacity alongside existing SCID testing and handle screening data securely.
NHS England made the award directly in March 2026, for £1.87m. The contract runs for two years and could be extended to March 2029.
- What
- Screening and population testing programmes
- Buyer
- NHS England
- Value
- £1.87m
- How it was bought
- Not published
- 3 bids
- Dates and next
- 5 Mar 2026